Search Within

Raymond E Baser

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (6)
  3. Research Letter (1)
Groups
  1. Department of Medicine (13)
  2. Hematologic Malignancies, Division of (13)
  3. Center for Hematologic Malignancies (10)
  4. Survivorship Research (10)
  5. Bone Marrow Transplant (9)
  6. Population Sciences Research Program (7)

More Groups

People
  1. Denise Correa (6)
  2. Sergio Giralt (6)
  3. Gunjan Shah (5)
  4. Michael Scordo (5)
  5. Miguel-Angel Perales (5)
  6. Parastoo Dahi (5)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2021 (1)
  4. 2020 (4)
  5. 2019 (1)
  6. 2016 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (3)
  2. Blood (2)
  3. Brain Imaging and Behavior (2)
  4. Journal of Clinical Oncology (2)
  5. Bone Marrow Transplantation (1)
  6. Cancers (1)

More Publications

Publishers
  1. Elsevier Inc. (4)
  2. American Society of Clinical Oncology (2)
  3. American Society of Hematology (2)
  4. Springer (2)
  5. Innovative Healthcare Institute (1)
  6. MDPI (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis- Final analysis of a phase II study
    Meeting Abstract

    Yang, J. T.; Yerramilli, D.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Baser, R. E.; Betof Warner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Pilot study of longitudinal geriatric assessment and neurocognitive evaluation in CAR T-cell therapy for older patients with relapsed refractory, large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Correa, D.; Elko, T. A.; Lobaugh, S.; Baser, R.; Koch, A.; Hanley, D. M.; Palomba, M. L.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating immune-related adverse events using PRO-CTCAE in a phase II study of ipilimumab for hormone-sensitive prostate cancer
    Journal Article

    Vargas P. de Almeida, D.; Anderson, J. M.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Cohn, E. D.; Baser, R. E.; Scher, H. I.; Autio, K. A.
    Journal of Immunotherapy and Precision Oncology (2023)

    Fulltext@MSK | Save
  • Neuroimaging and neurocognitive outcomes in older patients with multiple myeloma treated with chemotherapy and autologous stem cell transplantation
    Journal Article

    Correa, D. D.; Vachha, B. A.; Baser, R. E.; Koch, A.; Wong, P.; Gohel, S.; Giralt, S.; Root, J. C.
    Cancers (2023)

    Fulltext@MSK | Save
  • Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
    Research Letter

    Lin, R. J.; Baser, R. E.; Elko, T. A.; Korc-Grodzicki, B.; Shahrokni, A.; Maloy, M. A.; Young, J. W.; Tamari, R.; Shah, G. L.; Shaffer, B. C.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prognostic factors for postrelapse survival after ex vivo CD34(+)-selected (T cell-depleted) allogeneic hematopoietic cell transplantation in multiple myeloma
    Journal Article

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Scordo, M.; Ruiz, J. D.; Bryant, A.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of geriatric syndromes in 2-year, progression-free survivors of older allogeneic hematopoietic cell transplant recipients - A landmark analysis
    Meeting Abstract

    Lin, R. J.; Baser, R. E.; Elko, T. A.; Korc-Grodzicki, B.; Shahrokni, A.; Maloy, M. A.; Young, J. W.; Tamari, R.; Shah, G. L.; Shaffer, B. C.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Meeting Abstract

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC)
    Meeting Abstract

    Autio, K. A.; Antonarakis, E. S.; Baser, R.; Stein, M. N.; Shevrin, D. H.; Vaishampayan, U. N.; Mayer, T. M.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save